{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:20:57Z","timestamp":1762917657601},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11239-016-1343-6","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T12:08:29Z","timestamp":1456229309000},"page":"288-293","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Ancrod revisited: viscoelastic analyses of the effects of Calloselasma rhodostoma venom on plasma coagulation and fibrinolysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Vance G.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"issue":"Suppl 3","key":"1343_CR1","first-page":"18","volume":"54","author":"WR Bell Jr","year":"1997","unstructured":"Bell WR Jr (1997) Defibrinogenating enzymes. Drugs 54(Suppl 3):18\u201330","journal-title":"Drugs"},{"key":"1343_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/1040-8428(93)90018-Y","volume":"15","author":"RL Soutar","year":"1993","unstructured":"Soutar RL, Ginsberg JS (1993) Anticoagulant therapy with ancrod. Crit Rev Oncol Hematol 15:23\u201333","journal-title":"Crit Rev Oncol Hematol"},{"key":"1343_CR3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/0003-4975(94)90148-1","volume":"57","author":"AH O-Yurvati","year":"1994","unstructured":"O-Yurvati AH, Laub GW, Southgate TJ, McGrath TJ (1994) Heparinless cardiopulmonary bypass with ancrod. Ann Thorac Surg 57:1656\u20131658","journal-title":"Ann Thorac Surg"},{"key":"1343_CR4","first-page":"161","volume":"37","author":"MB Brennan","year":"1994","unstructured":"Brennan MB, MacKean GL (1994) Heparin-induced thrombosis treated with ancrod. Can J Surg 37:161\u2013164","journal-title":"Can J Surg"},{"key":"1343_CR5","first-page":"559","volume":"10","author":"BE Lewis","year":"1994","unstructured":"Lewis BE, Leya FS, Wallis D, Grassman E (1994) Failure of ancrod in the treatment of heparin-induced arterial thrombosis. Can J Cardiol 10:559\u2013561","journal-title":"Can J Cardiol"},{"key":"1343_CR6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.283.18.2395","volume":"283","author":"DG Sherman","year":"2000","unstructured":"Sherman DG, Atkinson RP, Chippendale T, Levin KA, Ng K, Futrell N, Hsu CY, Levy DE (2000) Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 283:2395\u20132403","journal-title":"JAMA"},{"key":"1343_CR7","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(06)69776-6","volume":"368","author":"MG Hennerici","year":"2006","unstructured":"Hennerici MG, Kay R, Bogousslavsky J, Lenzi GL, Verstraete M, Orgogozo JM, ESTAT investigators (2006) Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial. Lancet 368:1871\u20131878","journal-title":"Lancet"},{"key":"1343_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.thromres.2005.04.011","volume":"117","author":"N Lubenow","year":"2006","unstructured":"Lubenow N, Warkentin TE, Greinacher A, Wessel A, Sloane DA, Krahn EL, Magnani HN (2006) Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and\/or coumarin explain the rapid shift in clinical practice during the 1990s. Thromb Res 117:507\u2013515","journal-title":"Thromb Res"},{"key":"1343_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.jvca.2006.08.011","volume":"21","author":"GS Murphy","year":"2007","unstructured":"Murphy GS, Marymont JH (2007) Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 21:113\u2013126","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"1343_CR10","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1161\/STROKEAHA.109.565119","volume":"40","author":"DE Levy","year":"2009","unstructured":"Levy DE, del Zoppo GJ, Demaerschalk BM, Demchuk AM, Diener HC, Howard G, Kaste M, Pancioli AM, Ringelstein EB, Spatareanu C, Wasiewski WW (2009) Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program. Stroke 40:3796\u20133803","journal-title":"Stroke"},{"issue":"3","key":"1343_CR11","first-page":"CD000091","volume":"14","author":"Z Hao","year":"2012","unstructured":"Hao Z, Liu M, Counsell C, Wardlaw JM, Lin S, Zhao X (2012) Fibrinogen depleting agents for acute ischaemic stroke. Cochrane Database Syst Rev 14(3):CD000091","journal-title":"Cochrane Database Syst Rev"},{"key":"1343_CR12","first-page":"592","volume":"91","author":"WR Bell","year":"1978","unstructured":"Bell WR, Shapiro SS, Martinez J, Nossel HL (1978) The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man. J Lab Clin Med 91:592\u2013604","journal-title":"J Lab Clin Med"},{"key":"1343_CR13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/0041-0101(94)90320-4","volume":"32","author":"YM Dambisya","year":"1994","unstructured":"Dambisya YM, Lee TL, Gopalakrishnakone P (1994) Action of Calloselasma rhodostoma (Malayan pit viper) venom on human blood coagulation and fibrinolysis using computerized thromboelastography (CTEG). Toxicon 32:1619\u20131626","journal-title":"Toxicon"},{"key":"1343_CR14","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood.V96.8.2793","volume":"96","author":"CE Dempfle","year":"2000","unstructured":"Dempfle CE, Argiriou S, Kucher K, M\u00fcller-Peltzer H, R\u00fcbsamen K, Heene DL (2000) Analysis of fibrin formation and proteolysis during intravenous administration of ancrod. Blood 96:2793\u20132802","journal-title":"Blood"},{"key":"1343_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0049-3848(01)00391-7","volume":"104","author":"CE Dempfle","year":"2001","unstructured":"Dempfle CE, Alesci S, Kucher K, M\u00fcller-Peltzer H, R\u00fcbsamen K, Borggrefe M (2001) Plasminogen activation without changes in tPA and PAI-1 in response to subcutaneous administration of ancrod. Thromb Res 104:433\u2013438","journal-title":"Thromb Res"},{"key":"1343_CR16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-6632.2001.tb03507.x","volume":"936","author":"CE Dempfle","year":"2001","unstructured":"Dempfle CE, Argiriou S, Alesci S, Kucher K, M\u00fcller-Peltzer H, R\u00fcbsamen K, Heene DL (2001) Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity. Ann N Y Acad Sci 936:210\u2013214","journal-title":"Ann N Y Acad Sci"},{"key":"1343_CR17","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1161\/STROKEAHA.111.622753","volume":"42","author":"S Liu","year":"2011","unstructured":"Liu S, Marder VJ, Levy DE, Wang SJ, Yang F, Paganini-Hill A, Fisher MJ (2011) Ancrod and fibrin formation: perspectives on mechanisms of action. Stroke 42:3277\u20133280","journal-title":"Stroke"},{"key":"1343_CR18","doi-asserted-by":"crossref","first-page":"e0140887","DOI":"10.1371\/journal.pone.0140887","volume":"10","author":"J Fu","year":"2015","unstructured":"Fu J, Huang J, Lei M, Luo Z, Zhong X, Huang Y, Zhang H, Liu R, Tong J, He F (2015) Prevalence and impact on stroke in patients receiving maintenance hemodialysis versus peritoneal dialysis: a prospective observational study. PLoS ONE 10:e0140887","journal-title":"PLoS ONE"},{"key":"1343_CR19","first-page":"772","volume":"6","author":"X Li","year":"2014","unstructured":"Li X, Song G, Jin Y, Liu H, Li C, Han C, Ren S (2014) Higher level of heme oxygenase-1 in patients with stroke than TIA. J Thorac Dis 6:772\u2013777","journal-title":"J Thorac Dis"},{"key":"1343_CR20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/MAT.0000000000000144","volume":"60","author":"RW Matika","year":"2014","unstructured":"Matika RW, Nielsen VG, Steinbrenner EB, Sussman AN, Madhrira M (2014) Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide. ASAIO J 60:716\u2013721","journal-title":"ASAIO J"},{"key":"1343_CR21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/1871527314666150821110836","volume":"14","author":"VG Nielsen","year":"2015","unstructured":"Nielsen VG, Kulin W, LaWall JS, MacFarland FN, Chen A, Hadley HA, DaDeppo AJ, Steinbrenner EB, Matika RW (2015) Chronic migraineurs form circulating carboxyhemefibrinogen and iron-bound fibrinogen. CNS Neurol Disord 14:1079\u20131085","journal-title":"CNS Neurol Disord"},{"key":"1343_CR22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11239-015-1230-6","volume":"40","author":"N Shah","year":"2015","unstructured":"Shah N, Welsby IJ, Fielder MA, Jacobsen WK, Nielsen VG (2015) Sickle cell disease is associated with iron mediated hypercoagulability. J Thromb Thrombolysis 40:182\u2013185","journal-title":"J Thromb Thrombolysis"},{"key":"1343_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12504","author":"VG Nielsen","year":"2016","unstructured":"Nielsen VG, Redford DT, Boyle PK (2016) Effect of iron and carbon monoxide on fibrinogenase-like degradation of plasmatic coagulation by venoms of six Agkistrodon species. Basic Clin Pharmacol Toxicol. doi: 10.1111\/bcpt.12504","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1343_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.mbc.0000198047.35010.77","volume":"17","author":"VG Nielsen","year":"2006","unstructured":"Nielsen VG, Cohen BM, Cohen E (2006) Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 17:75\u201381","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1343_CR25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MBC.0b013e3280111a8e","volume":"18","author":"TC Ellis","year":"2007","unstructured":"Ellis TC, Nielsen VG, Marques MB, Kirklin JK (2007) Thrombelastographic measures of clot propagation: a comparison of alpha to maximum rate of thrombus generation. Blood Coagul Fibrinolysis 18:45\u201348","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1343_CR26","doi-asserted-by":"crossref","unstructured":"Nielsen VG, Boyer LV (2016) Iron and carbon monoxide attenuate degradation of plasmatic coagulation by Crotalus atrox venom. Blood Coagul Fibrinolysis (in press)","DOI":"10.1097\/MBC.0000000000000440"},{"key":"1343_CR27","doi-asserted-by":"crossref","unstructured":"Nielsen VG, Redford DT, Boyle PK (2016) Effect of iron and carbon monoxide on fibrinogenase-like degradation of plasmatic coagulation by venoms of four Crotalus species. Blood Coagul Fibrinolysis (in press)","DOI":"10.1097\/MBC.0000000000000529"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1343-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-016-1343-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-016-1343-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:08:46Z","timestamp":1600214926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-016-1343-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1007\/s11239-016-1343-6","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}